Skip to content

Continuous Wireless Monitoring of Vital Signs and Automated Alerts of Postsurgical Patient Deterioration.

Continuous Wireless Monitoring of Vital Signs and Automated Alerts of Patient Deterioration vs. Routine Monitoring of High-risk Patients After Major Surgery. A Randomized Controlled Trial.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04640415
Acronym
WARD-RCT-SX
Enrollment
400
Registered
2020-11-23
Start date
2021-01-11
Completion date
2023-05-30
Last updated
2023-06-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Complication,Postoperative

Keywords

Wireless Monitoring, Vital signs, Physiologic deterioration

Brief summary

The primary aim of the current study is to assess the effect of continuous wireless vital sign monitoring with generation of real-time alerts, compared to blinded monitoring without alerts on the cumulative duration of any severely deviating vital signs in patients admitted to general hospital wards after major surgery. We hypothesize that continuous vital signs monitoring, and real-time alerts will reduce the cumulative duration of severely deviating vital signs.

Interventions

DEVICEActive Alarms

Intervention consists of actively alerting staff personnel if physiologic vital signs, deviates from certain thresholds for more than a set duration. Continuous vital sign data will also be available to clinical staff.

Sponsors

Aarhus University Hospital
CollaboratorOTHER
Odense University Hospital
CollaboratorOTHER
Bispebjerg Hospital
CollaboratorOTHER
Technical University of Denmark
CollaboratorOTHER
Rigshospitalet, Denmark
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
50 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Admission for acute or elective major abdominal (laparotomy/laparoscopy), major orthopedic, major urologic, or arterial vascular surgery. * Estimated duration of surgery ≥2 hours and at least two expected overnight stays. * Randomization and commencement of continuous wireless monitoring possible within 24 hours postoperatively

Exclusion criteria

* Patient expected not to cooperate with study procedures. * Allergy to plaster or silicone. * Impaired cognitive function (in uncertain cases assessed by a Mini Mental State Examination\] score \< 24) * Patients admitted for palliative care only (i.e. no active treatment). * Planned admission to unit using continuous vital sign monitoring (i.e. an intermediary care/telemetry unit). * Patients previously enrolled in the medical WARD RCT. * Patients with a pacemaker or Implantable Cardioverter Defibrillator (ICD) device. * Inability to give informed consent.

Design outcomes

Primary

MeasureTime frameDescription
Cumulative durationDuring monitoring, for a maximum of up to 5 postoperative days or until discharge.Cumulative duration of one or more deviations in vital signs. List of vital signs, and normal limits detailed in protocol.

Secondary

MeasureTime frameDescription
Frequency of sustained deviation alertsDuring monitoring, for a maximum of up to 5 postoperative days or until discharge.Frequency of each of the sustained deviations in vital signs. List of vital signs, and normal limits detailed in the protocol.
Any adverse event7 days and 30 days after start of monitoringAny adverse event. Criteria for each defined in protocol. Results will be compared between the case and control arm, on when it a diagnosis is made. Based on information in patient electronic medical file.
Any serious adverse event7 days and 30 days after start of monitoringAny serious adverse event. Criteria for each defined in protocol. Serious Adverse Events will be determined using the criteria as defined in ICH-GCP terms. Results will be compared between the case and control arm, on when it a diagnosis is made. Based on information in patient electronic medical file.

Other

MeasureTime frameDescription
Patient related post-admission healthcare expenses2 yearsTotal patient-related healthcare expenses in patients experiencing adverse clinical outcomes compared to patients without such outcomes and the effect of the study intervention on expenses
Staff response time (intervention group only)During monitoring, for a maximum of up to 5 postoperative days or until discharge, whichever comes firstTime from the staff is notified by app, until they respond by selecting 'check on patient' in app Stratified according to time of day
Length of hospital stay30 postoperative days and 6 monthsLength of hospital stay

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 8, 2026